Skip to main content
Log in

Development and Validation of LC–MS/MS Method for the Quantitation of Infliximab in Human Serum

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

Liquid chromatography tandem mass spectrometry (LC–MS/MS), especially triple-quadrupole mass spectrometry, has become an attractive alternative method to ligand binding assays for therapeutic monoclonal antibody quantification in biological samples, but the use of an internal standard with infliximab LC–MS/MS assays has not been reported yet. In this study, an improved LC–MS/MS method for quantification of infliximab in human serum was developed and validated. A surrogate peptide was used as a representative of infliximab which was cleaved for the quantification of infliximab based on LC–MS/MS assay. A stable isotope-labeled signature peptide was used as the internal standard (IS). The results showed linearity in the range of 0.39–100 μg mL−1; the lower limit of quantification (LLOQ), and the lower limit of detection were 0.39 and 0.0975 μg mL−1, respectively. The quality control (QC) data showed that the within-run, between-run precision (%RSD) and accuracy (%RE) conformed to the acceptance criteria of ±15 % for calibration standards and QCs (±20 % at the LLOQ). Other validation parameters including selectivity, methanol precipitation efficiency, serum matrix effect, stability, and auto-sampler carry-over were also evaluated. This improved LC–MS/MS method might be a promising LC–MS-based methodology for pharmacokinetic studies of other recombinant monoclonal antibodies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Balkwill F (2009) Nat Rev Cancer 9:361–371

    Article  CAS  Google Scholar 

  2. Elliott MJ, Maini R, Feldmann M, Long-Fox A, Charles P, Bijl J, Woody J (1994) Lancet 344:1125–1127

    Article  CAS  Google Scholar 

  3. Van Dullemen H, Van Deventer S, Hommes D, Bijl H, Jansen J, Tytgat G (1995) Gastroenterology 109:129–135

    Article  Google Scholar 

  4. Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P (1993) Mol Immunol 30:1443–1453

    Article  CAS  Google Scholar 

  5. Martínez-Borra J, López-Larrea C, González S, Fuentes D, Dieguez A, Deschamps EM, Perez-Pariente J, López-Vázquez A, de Francisco R, Rodrigo L (2002) Am J Gastroenterol 97:2350–2356

    Google Scholar 

  6. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ (1997) New Engl J Med 337:1029–1036

    Article  CAS  Google Scholar 

  7. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W (2002) Lancet 359:1541–1549

    Article  CAS  Google Scholar 

  8. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, Van Hogezand R, Podolsky DK, Sands BE, Braakman T, DeWoody KL (1999) New Engl J Med 340:1398–1405

    Article  CAS  Google Scholar 

  9. Chey WY (2001) Inflamm Bowel Dis 7:S30–S33

    Article  Google Scholar 

  10. Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Danielsson Å, Verbaan H (2005) Gastroenterology 128:1805–1811

    Article  Google Scholar 

  11. Maini SR (2004) Rheum Dis Clin N Am 30:329–347

    Article  Google Scholar 

  12. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-lhle E, Kellner H, Krause A, Schneider M (2002) Lancet 359:1187–1193

    Article  CAS  Google Scholar 

  13. Chaudhari U, Romano P, Mulcahy L, Dooley L, Baker D, Gottlieb A (2001) Lancet 357:1842–1847

    Article  CAS  Google Scholar 

  14. Zippi M, Cassieri C, Avallone EV, Pica R (2013) World J Clin Cases 1:191

    Article  Google Scholar 

  15. Brown E, Charles K, Hoare S, Rye R, Jodrell D, Aird R, Vora R, Prabhakar U, Nakada M, Corringham R (2008) Ann Oncol 19:1340–1346

    Article  CAS  Google Scholar 

  16. Gisbert JP, Panés J (2009) Am J Gastroenterol 104:760–767

    Article  CAS  Google Scholar 

  17. Miheller P, Kiss LS, Lorinczy K, Lakatos PL (2012) Expert Opin Biol Ther 12:179–192

    Article  CAS  Google Scholar 

  18. Regueiro M, Siemanowski B, Kip KE, Plevy S (2007) Inflamm Bowel Dis 13:1093–1099

    Article  Google Scholar 

  19. Mulleman D, Méric J-C, Paintaud G, Ducourau E, Magdelaine-Beuzelin C, Valat J-P, Goupille P, GICC CNdlRSU (2009) Arthritis Res Ther 11(6):R178

    Article  Google Scholar 

  20. Dasgupta A (2008) Introduction to therapeutic drug monitoring. In: Dasgupta A (ed) Handbook of drug monitoring methods. Springer, pp 1–39

  21. Baert F, Noman M, Vermeire S, Van Assche G, D’Haens G, Carbonez A, Rutgeerts P (2003) New Engl J Med 348:601–608

    Article  CAS  Google Scholar 

  22. Aarden L, Ruuls SR, Wolbink G (2008) Curr Opin Immunol 20:431–435

    Article  CAS  Google Scholar 

  23. Anderson NL, Anderson NG, Haines LR, Hardie DB, Olafson RW, Pearson TW (2004) J Proteome Res 3:235–244

    Article  CAS  Google Scholar 

  24. Vande Casteele N, Buurman D, Sturkenboom M, Kleibeuker J, Vermeire S, Rispens T, Kleij D, Gils A, Dijkstra G (2012) Aliment Pharm Therap 36:765–771

    Article  CAS  Google Scholar 

  25. Wang S-L, Hauenstein S, Ohrmund L, Shringarpure R, Salbato J, Reddy R, McCowen K, Shah S, Lockton S, Chuang E (2013) J Pharm Biomed Anal 78:39–44

    Article  Google Scholar 

  26. Rawlins ML, Roberts WL (2004) Clin Chem 50:2338–2344

    Article  CAS  Google Scholar 

  27. Mongia SK, Rawlins ML, Owen WE, Roberts WL (2006) Am J Clin Pathol 125:921–927

    Article  CAS  Google Scholar 

  28. La’ulu SL, Roberts WL (2007) Am J Clin Pathol 127:436–440

    Article  Google Scholar 

  29. Palandra J, Finelli A, Zhu M, Masferrer J, Neubert H (2013) Anal Chem 85:5522–5529

    Article  CAS  Google Scholar 

  30. Rotmensch S, Cole LA (2000) Lancet 355:712–715

    Article  CAS  Google Scholar 

  31. Morgan BR, Tarter TH (2001) J Urol 166:2311–2312

    Article  CAS  Google Scholar 

  32. Ciccimaro E, Blair IA (2010) Bioanalysis 2:311–341

    Article  CAS  Google Scholar 

  33. Zhang SW, Jian W (2014) Rev Anal Chem 33:31–47

    Article  Google Scholar 

  34. Becker JO, Hoofnagle AN (2012) Bioanalysis 4:281–290

    Article  CAS  Google Scholar 

  35. Hilger M, Bonaldi T, Gnad F, Mann M (2009) Mol Cell Proteomics 8:1908–1920

    Article  CAS  Google Scholar 

  36. Dephoure N, Zhou C, Villén J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP (2008) Proc Natl Acad Sci USA 105:10762–10767

    Article  CAS  Google Scholar 

  37. Heudi O, Barteau S, Zimmer D, Schmidt J, Bill K, Lehmann N, Bauer C, Kretz O (2008) Anal Chem 80:4200–4207

    Article  CAS  Google Scholar 

  38. Desiderio DM, Kai M (1983) Biol Mass Spectrom 10:471–479

    Article  CAS  Google Scholar 

  39. Kennedy JJ, Abbatiello SE, Kim K, Yan P, Whiteaker JR, Lin C, Kim JS, Zhang Y, Wang X, Ivey RG (2013) Nat Methods 11:149–155

    Article  Google Scholar 

  40. Ji C, Sadagopan N, Zhang Y, Lepsy C (2009) Anal Chem 81:9321–9328

    Article  CAS  Google Scholar 

  41. Steenholdt C, Bendtzen K, Brynskov J, Ainsworth MA (2014) Am J Gastroenterol 109:1055–1064

    Article  CAS  Google Scholar 

  42. Jiang H, Zeng J, Titsch C, Voronin K, Akinsanya B, Luo L, Shen H, Desai DD, Allentoff A , Aubry A-Fo (2013) Anal Chem 85:9859–9867

    Article  CAS  Google Scholar 

  43. FDA (2001) Guidance for industry: bioanalytical method validation, pp 1–21

  44. Zimmer D (2014) Bioanalysis 6:13–19

    Article  CAS  Google Scholar 

  45. Khanna R, Sattin B, Afif W, Benchimol E, Bernard EJ, Bitton A, Bressler B, Fedorak R, Ghosh S, Greenberg G (2013) Aliment Pharm Therap 38:447–459

    Article  CAS  Google Scholar 

  46. Li H, Ortiz R, Tran L, Hall M, Spahr C, Walker K, Laudemann J, Miller S, Salimi-Moosavi H, Lee JW (2012) Anal Chem 84:1267–1273

    Article  CAS  Google Scholar 

  47. Brun V, Dupuis A, Adrait A, Marcellin M, Thomas D, Vandenesch F, Garin J (2007) Mol Cell Protemics 6:2139–2149

    Article  CAS  Google Scholar 

  48. Beynon RJ, Doherty MK, Pratt JM, Gaskell SJ (2005) Nat Methods 2:587–589

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank Waters Company Laboratories for cooperation with us. This work was supported by grants from the Natural Science Foundation of China (81330061), Ministry of Science and Technology of China (973 projects 2010CB833605 and 863 projects 2014AA021004), State Key Project for New Drug Development (2013ZX09101021; 2013ZX09401303), Shanghai Commission of Science and Technology (Key Laboratory and Projects 13DZ1930100), and Shanghai Excellent technical leader (13XD1424000).

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sheng Hou.

Additional information

X. Peng, B. Liu, Y. Li were contributed equally to this work.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 472 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peng, X., Liu, B., Li, Y. et al. Development and Validation of LC–MS/MS Method for the Quantitation of Infliximab in Human Serum. Chromatographia 78, 521–531 (2015). https://doi.org/10.1007/s10337-015-2866-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-015-2866-2

Keywords

Navigation